retatrutide triple hormone receptor agonist metabolic Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial Retatrutide (not yet approved in

You may experience mild gas or bloating as the microbiome shifts

Patient autonomy

The result is elevated but controlled GH levels with a much better safety profile

Once withdrawn, you may experience: Increased hunger cues throughout the day Reduced meal satisfaction, even after normal portions Cravings for calorie-dense foods, especially sugar and refined carbs Without proactive strategies, these shifts can contribute to rapid weight regain

If you are experiencing rapid weight loss since starting Ozempic treatment, consider talking with your healthcare professional or a registered dietitian to ensure your weight loss is gradual and sustainable